Maggie Bobbin
About Maggie Bobbin
Maggie Bobbin serves as the Associate Director at CERo Therapeutics, Inc., where she has worked since 2021. She has extensive experience in genome editing technologies and synthetic biology, with a background in RNA research and DNA vaccine development.
Work at Cero Therapeutics
Maggie Bobbin serves as the Associate Director at Cero Therapeutics, Inc. since 2021. In this role, she focuses on advancing the company's initiatives in genome editing and synthetic biology. Her expertise includes the development of gene targeting technologies, particularly in the context of CAR-T cell therapies. Bobbin's contributions are integral to the company's research and development efforts.
Previous Experience at Refuge Biotechnologies
Maggie Bobbin worked at Refuge Biotechnologies from 2019 to 2021. Initially, she held the position of Scientist for two years, where she developed synthetic biology approaches to regulate gene targeting in CAR-T cells. In 2021, she transitioned to the role of Principal Scientist for a brief period of five months, further enhancing her experience in the biotechnology sector.
Academic Background and Research
Maggie Bobbin completed her Doctor of Philosophy (PhD) at the Irell & Manella Graduate School of Biological Sciences from 2009 to 2015. Her research during this time included DNA vaccine development and RNA folding. Prior to her PhD, she earned a Bachelor of Science (BS) in microbiology from the University of Minnesota-Twin Cities, where she conducted research as an Undergraduate Researcher from 2006 to 2009.
Research Focus and Expertise
Maggie Bobbin has spent four years developing genome editing technologies, including CRISPR/Cas and zinc finger nucleases. Her research has involved quantifying off-target effects in these technologies, which is critical for ensuring the precision of genome editing applications. Additionally, she has conducted research on therapeutic mRNA development, contributing to advancements in RNA technology.
Experience at City of Hope
Maggie Bobbin worked as a Graduate Student at City of Hope from 2009 to 2015. During her time there, she focused on various aspects of biological sciences, contributing to her extensive knowledge in the field. This experience complemented her academic pursuits and research interests in genome editing and synthetic biology.